These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat. Amacher DE, Beck R, Schomaker SJ, Kenny CV. Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043 [Abstract] [Full Text] [Related]
6. Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Cai Y, Nelson BD, Li R, Luciakova K, dePierre JW. Arch Biochem Biophys; 1996 Jan 01; 325(1):107-12. PubMed ID: 8554334 [Abstract] [Full Text] [Related]
7. Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins. Bartles JR, Khuon S, Lin XH, Zhang LQ, Reddy JK, Rao MS, Isoye ST, Nehme CL, Fayos BE. Cancer Res; 1990 Feb 01; 50(3):669-76. PubMed ID: 2404574 [Abstract] [Full Text] [Related]
8. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators. Watanabe T, Okawa S, Itoga H, Imanaka T, Suga T. Biochim Biophys Acta; 1992 Apr 30; 1135(1):84-90. PubMed ID: 1591274 [Abstract] [Full Text] [Related]
9. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Reddy JK, Jirtle RL, Watanabe TK, Reddy NK, Michalopoulos G, Qureshi SA. Cancer Res; 1984 Jun 30; 44(6):2582-9. PubMed ID: 6372995 [Abstract] [Full Text] [Related]
10. Effects of perfluoro-n-octanoic acid, perfluoro-n-decanoic acid, and clofibrate on hepatic phosphorus metabolism in rats and guinea pigs in vivo. Reo NV, Goecke CM, Narayanan L, Jarnot BM. Toxicol Appl Pharmacol; 1994 Feb 30; 124(2):165-73. PubMed ID: 8122261 [Abstract] [Full Text] [Related]
13. Growth regulation by peroxisome proliferators: opposing activities in early and late G1. Ledwith BJ, Johnson TE, Wagner LK, Pauley CJ, Manam S, Galloway SM, Nichols WW. Cancer Res; 1996 Jul 15; 56(14):3257-64. PubMed ID: 8764118 [Abstract] [Full Text] [Related]
16. Effect of feeding clofibrate-containing diet on the hepatic NAD+ level in rats. Loo Y, Shin M, Yamashita Y, Ishigami M, Sasaki M, Sano K, Umezawa C. J Nutr Sci Vitaminol (Tokyo); 1995 Jun 15; 41(3):341-7. PubMed ID: 7472678 [Abstract] [Full Text] [Related]
17. Induction of cytochrome P4504A by the peroxisome proliferator perfluoro-n-octanoic acid. Diaz MJ, Chinje E, Kentish P, Jarnot B, George M, Gibson G. Toxicology; 1994 Jan 26; 86(1-2):109-22. PubMed ID: 8134918 [Abstract] [Full Text] [Related]
18. Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators. Crane DI, Zamattia J, Masters CJ. Mol Cell Biochem; 1990 Aug 10; 96(2):153-61. PubMed ID: 2274048 [Abstract] [Full Text] [Related]
19. Clofibrate and di(2-ethylhexyl)phthalate increase ubiquinone contents without affecting cholesterol levels. Aberg F, Appelkvist EL. Acta Biochim Pol; 1994 Aug 10; 41(3):321-9. PubMed ID: 7856403 [Abstract] [Full Text] [Related]
20. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta. Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T. Eur J Pharmacol; 2006 Nov 07; 549(1-3):124-32. PubMed ID: 16979161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]